Effects of cigarette smoking and carbon monoxide on nicotine and cotinine metabolism

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 6, 2000, Pages 653-659

  Benowitz, Neal L ^a,b   Jacob III, Peyton ^a,b  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; COTININE; NICOTINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; MALE; METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0034124565     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.107086     Document Type: Article

References (20)

1. 1. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-30.
2. 2. Lee BL, Benowitz NL, Jacob P III. Influence of tobacco abstinence on the disposition kinetics and effects of nicotine. Clin Pharmacol Ther 1987;41:474-9.
3. 3. Benowitz NL, Jacob P III. Nicotine and cotinine elimination pharmacokinetics in smokers and nonsmokers. Clin Pharmacol Ther 1993;53:316-23.
4. 4. Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet 1999;36:425-38.
5. 5. Benowitz NL, Jacob P III. Pharmacokinetics and metabolism of nicotine and related alkaloids. In: Arneric SP, Brioni JD, editors. Neuronal nicotinic receptors. New York: Wiley-Liss; 1999. p. 213-34.
6. 6. Benowitz NL, Jacob P III, Fong I, Gupta S. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994; 268:296-303.
7. 7. Messina ES, Tyndale RF, Sellers EM. A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 1997;282:1608-14.
8. 8. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 1996;24:1212-7.
9. 9. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, et al. Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 1996; 277:1010-5.
10. 10. Zevin S, Jacob P III, Benowitz NL. Cotinine effects on nicotine metabolism. Clin Pharmacol Ther 1997;61:649-54.
11. 11. Leemann T, Bonnabry P, Dayer P. Selective inhibition of major drug metabolizing cytochrome P450 isozymes in human liver microsomes by carbon monoxide. Life Sci 1994;54:951-6.
12. 12. Montgomery MR, Rubin RJ. The effect of carbon monoxide inhalation on in vivo drug metabolism in the rat. J Pharmacol Exp Ther 1971;179:465-73.
13. 13. Jacob P III, Shulgin A, Yu L, Benowitz NL. Determination of the nicotine metabolite trans-3′-hydroxycotinine in smokers using gas chromatography with nitrogen-selective detection or selected ion monitoring. J Chromatogr 1992;583:145-54.
14. 2 in humans. Biol Mass Spectrom 1991;20:247-52.
15. 15. Benowitz NL, Jacob P III. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther 1994;56:483-93.
16. 16. Stalhandski T, Slanina P. Nicotyrine inhibits in vivo metabolism of nicotine without increasing its toxicity. Toxicol Appl Pharmacol 1982;65:366-72.
17. 17. Fleischmann R, Remmer H, Starz U. Induction of cytochrome P-448 isoenzymes and related glucuronyl-transferases in the human liver by cigarette smoking. Eur J Clin Pharmacol 1986;30:475-80.
18. 18. Ochs HR, Greenblatt DJ, Otten H. Disposition of oxazepam in relation to age, sex, and cigarette smoking. Klin Wochenschr 1981;59:899-903.
19. 19. Grech Belanger O, Gilbert M, Turgeon J, LeBlanc PP. Effect of cigarette smoking on mexiletine kinetics. Clin Pharmacol Ther 1985;37:638-43.
20. 20. Walle T, Walle UK, Cowart TD, Conradi EC, Gaffney TE. Selective induction of propranolol metabolism by smoking: additional effects on renal clearance of metabolites. J Pharmacol Exp Ther 1987;241:928-33.